Telesis Bio Inc (TBIO) Stock Price, Quote & News

Company Profile

Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation...

Industry: Medical Devices

Sector: Healthcare

Phone: 858 228 4115

Website: telesisbio.com

Address:

10431 Wateridge Circle, Suite 150, San Diego, United States

Parobull May. 9 at 3:26 AM

Keep an eye on ticker SGMA. It hasn’t had its big volume breakout yet, but the TWC Group just disclosed an 11% stake. With a portfolio valued at over $11 billion and $100 billion in assets, that’s a notable endorsement. SGMA also has a long-standing presence on the exchange with virtually no history of dilution or reverse splits. They haven’t released news in a while, but with the recent 13G filing and the vice president’s departure, I believe significant updates or press releases could be on the horizon. Aslo watch $APVO $TBIO $BJDX $AREB these have low borrows and small floats

0 · Reply

PenkeInvesting Apr. 11 at 5:42 AM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Telesis Bio Inc.. Is that bullish or bearish? $TBIO #RsiOverbought #PINK

0 · Reply

NVDAMillionaire Mar. 26 at 4:35 PM

$TBIO Digging TBIO's mRNA play. Sanofi collab looks promising. CF program showing potential. Might take a small position if Phase 1/2 data continues to look strong. Watching closely. standout article: https://beyondspx.com/article/translate-bio-inc-tbio-a-biotech-innovator-at-the-forefront-of-mrna-therapeutics

2 · Reply

JOEYBUYDEN Feb. 13 at 6:00 PM

$TBIO wtf; wants me to buy back in huh? 😈🎲🎲🎲🎲🎲🎲🎲🎲🎲🎲🎲

0 · Reply

Parobull Jan. 24 at 4:17 AM

MCVT is climbing up the leaderboards for a $DWTX $RNAX type squeeze! Just look at MCVT for a swing as well, i think this has a DWTX type move soon. The only low float with profitability+cash flow positive and no dilution or dilution risk $NCEL $BJDX $TBIO 3 other ones with low borrow and small floats!

0 · Reply

starforce33 Jan. 22 at 4:55 PM

$TBIO what's the story here why so low we need cash or something? Last time I traded tbio it was in the 3s 4s

1 · Reply

Parobull Jan. 16 at 1:14 AM

Watch MCVT, profitable undervalued low float! cashflow positive, with a share repurchase and recent news and more news coming. $10+ potential! $BJDX $XCUR $NCEL $TBIO

0 · Reply

JOEYBUYDEN Jan. 7 at 9:25 PM

$TBIO 🖕🏽🫡

0 · Reply

JOEYBUYDEN Jan. 6 at 5:42 PM

$TBIO put this POS in the dirt! 🪦

0 · Reply

WatchTheseTickers Dec. 30 at 4:53 AM

All eyes on ARTW this week! No dilution X micro float X 249% increase in backlog X TRUMP IS COMING IN SAVING THE AGRICULTURE SECTOR + ARTW can see a massive short squeeze! $BJDX $TBIO $UAVS $HGAS 4 other stocks that could squeeze too

0 · Reply

Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis

Sep 10, 2024, 4:30 PM EDT - 1 year ago

Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market

Aug 7, 2024, 4:05 PM EDT - 1 year ago

Telesis Bio Reports Second Quarter and First Half 2024 Financial Results

May 9, 2024, 4:05 PM EDT - 1 year ago

Telesis Bio Reports First Quarter 2024 Financial Results

May 6, 2024, 4:05 PM EDT - 2 years ago

Telesis Bio Announces Reverse Stock Split

Apr 18, 2024, 9:00 AM EDT - 2 years ago

Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership

Mar 28, 2024, 4:05 PM EDT - 2 years ago

Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 26, 2024, 9:15 AM EST - 2 years ago

Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results

Nov 13, 2023, 4:22 PM EST - 2 years ago

Telesis Bio Reports Third Quarter 2023 Financial Results

Nov 7, 2023, 9:00 AM EST - 2 years ago

Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023

Nov 3, 2023, 12:00 PM EDT - 2 years ago

Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA

Sep 28, 2023, 3:48 PM EDT - 2 years ago

Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS

Aug 29, 2023, 4:05 PM EDT - 2 years ago

Telesis Bio Appoints William J. Kullback Chief Financial Officer

Aug 11, 2023, 4:02 PM EDT - 2 years ago

Telesis Bio, Inc. (TBIO) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 4:05 PM EDT - 2 years ago

Telesis Bio Reports Second Quarter 2023 Financial Results

Aug 3, 2023, 5:00 PM EDT - 2 years ago

Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023

Jun 8, 2023, 9:05 AM EDT - 2 years ago

Telesis Bio to Present at Jefferies Healthcare Conference 2023

Jun 6, 2023, 3:00 AM EDT - 2 years ago

Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023

Jun 5, 2023, 5:30 PM EDT - 3 years ago

Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock

May 31, 2023, 5:29 PM EDT - 3 years ago

Telesis Bio Secures Financing of $28.0 Million

May 23, 2023, 9:00 AM EDT - 3 years ago

Telesis Bio to Present at SynBioBeta 2023

May 22, 2023, 12:00 PM EDT - 3 years ago

Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit

May 18, 2023, 10:00 AM EDT - 3 years ago

Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit

May 15, 2023, 9:00 AM EDT - 3 years ago

Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)

May 11, 2023, 4:05 PM EDT - 3 years ago

Telesis Bio Reports First Quarter 2023 Financial Results

Apr 27, 2023, 4:05 PM EDT - 3 years ago

Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023

Mar 31, 2023, 9:00 AM EDT - 3 years ago

Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up

Mar 25, 2023, 10:28 AM EDT - 3 years ago

Telesis Bio, Inc. (TBIO) Q4 2022 Earnings Call Transcript

Mar 21, 2023, 4:05 PM EDT - 3 years ago

Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance

Mar 16, 2023, 6:00 AM EDT - 3 years ago

Telesis Bio to Present at Festival of Biologics Conference

Mar 14, 2023, 6:00 AM EDT - 3 years ago

Telesis Bio to Present at RNA Leaders Europe Congress

Mar 9, 2023, 4:30 PM EST - 3 years ago

Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023

Feb 27, 2023, 9:00 AM EST - 3 years ago

Telesis Bio to Present at the Cowen 43rd Annual Healthcare Conference

Feb 16, 2023, 9:00 AM EST - 3 years ago

Telesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation

Jan 9, 2023, 9:00 AM EST - 3 years ago

Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial Results

Nov 12, 2022, 8:53 PM EST - 3 years ago

Telesis Bio, Inc. (DNAY) Q3 2022 Earnings Call Transcript

Nov 8, 2022, 4:10 PM EST - 3 years ago

Telesis Bio Inc. Reports Third Quarter 2022 Financial Results

Nov 2, 2022, 4:19 PM EDT - 3 years ago

Telesis Bio to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 8

Oct 19, 2022, 9:00 AM EDT - 3 years ago

Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrument

Oct 12, 2022, 9:00 AM EDT - 3 years ago

Codex DNA Announces Plan to Change Corporate Name to Telesis Bio

Oct 4, 2022, 9:00 AM EDT - 3 years ago

Codex DNA Expands Application of Proprietary Error Correction Technology

Sep 26, 2022, 7:00 AM EDT - 3 years ago

Codex DNA Showcases Next Generation Automated Synthetic Biology Workstation at World of Technology & Science in Utrecht, Netherlands

Sep 19, 2022, 7:00 AM EDT - 3 years ago

Codex DNA Debuts Next-Generation Automated Synthetic Biology Workstation

Aug 14, 2022, 8:26 AM EDT - 3 years ago

Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q2 2022 Results - Earnings Call Transcript

Aug 9, 2022, 4:10 PM EDT - 3 years ago

Codex DNA Reports Second Quarter 2022 Financial Results

Aug 2, 2022, 4:05 PM EDT - 3 years ago

Codex DNA to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022

Jun 2, 2022, 8:03 AM EDT - 4 years ago

Codex DNA to Present at the 2022 Jefferies Healthcare Conference

Jun 1, 2022, 8:03 AM EDT - 4 years ago

Codex DNA Showcases Automated Synthetic Biology Solutions for Accelerating Discovery Workflows at the Antibody Engineering and Therapeutics Europe Conference

May 14, 2022, 11:28 PM EDT - 4 years ago

Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q1 2022 Results - Earnings Call Transcript

May 10, 2022, 4:05 PM EDT - 4 years ago

Codex DNA Reports First Quarter 2022 Financial Results

Parobull May. 9 at 3:26 AM

0 · Reply

PenkeInvesting Apr. 11 at 5:42 AM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Telesis Bio Inc.. Is that bullish or bearish? $TBIO #RsiOverbought #PINK

0 · Reply

NVDAMillionaire Mar. 26 at 4:35 PM

2 · Reply

JOEYBUYDEN Feb. 13 at 6:00 PM

$TBIO wtf; wants me to buy back in huh? 😈🎲🎲🎲🎲🎲🎲🎲🎲🎲🎲🎲

0 · Reply

Parobull Jan. 24 at 4:17 AM

0 · Reply

starforce33 Jan. 22 at 4:55 PM

$TBIO what's the story here why so low we need cash or something? Last time I traded tbio it was in the 3s 4s

1 · Reply

Parobull Jan. 16 at 1:14 AM

Watch MCVT, profitable undervalued low float! cashflow positive, with a share repurchase and recent news and more news coming. $10+ potential! $BJDX $XCUR $NCEL $TBIO

0 · Reply

JOEYBUYDEN Jan. 7 at 9:25 PM

$TBIO 🖕🏽🫡

0 · Reply

JOEYBUYDEN Jan. 6 at 5:42 PM

$TBIO put this POS in the dirt! 🪦

0 · Reply

WatchTheseTickers Dec. 30 at 4:53 AM

0 · Reply

Parobull Dec. 18 at 2:28 PM

All eyes on Ticker = GV Momentum and eyes are shifting here for the next parabolic run! $BJDX $SBFM $CYCN $TBIO are all very highly shorted as well!

0 · Reply

2pug Dec. 16 at 3:15 PM

$TBIO what is up?

0 · Reply

Noideawhatimdoing23 Dec. 7 at 8:24 PM

$TBIO so why exactly did this tank..?

0 · Reply

NVDAMillionaire Dec. 5 at 1:40 AM

$TBIO Translate Bio, Inc. (TBIO): Navigating the Frontier of mRNA Therapeutics https://beyondspx.com/article/translate-bio-inc-tbio-navigating-the-frontier-of-mrna-therapeutics

1 · Reply

green_going_up Dec. 4 at 5:53 PM

$TBIO Beckman Coulter should just acquire this firm.

0 · Reply

JOEYBUYDEN Nov. 25 at 3:54 PM

$TBIO nightmare scenario. Do not invest!

0 · Reply

JOEYBUYDEN Nov. 13 at 5:25 PM

$TBIO yikes

0 · Reply

Market Cap	92,000.00
Revenue (ttm)	27.51M
Net Income (ttm)	-47.72M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-173.46%
Debt to Equity Ratio	-0.21

Volume	1,000
Avg Vol	952
Day's Range	N/A - N/A
Shares Out	1.80M
Stochastic %K	0%
Beta	2.52
Analysts	Strong Buy
Price Target	$4.00